Season 8 · Episode 45
S8 Ep45: FDA Approval Insights: Omidubicel in Blood Cancers Requiring Transplant
OncLive® On Air · OncLive® On Air
May 15, 20239m 35s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Horwitz discusses the FDA approval of omidubicel in patients with blood cancers, key efficacy and safety data from the pivotal phase 3 trial, and the benefits omidubicel provides beyond improved neutrophil engraftment.